Yuanfang Zhu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yuanfang Zhu has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Fei Ji
Department of Obstetrics and Gynecology, Shenzhen Baoan Women’s and Children’s Hospital, Jinan University, Shenzhen, China
3 shared publicationsShaoyun Chen
Maternal-Fetal Medicine Institute, Shenzhen Baoan Women’s and Children’s Hospital, Jinan University, Shenzhen, China
2 shared publicationsXiaoling Lin
Department of Obstetrics and Gynecology, the first Affiliated Hospital of Jinan University, Guangzhou, China
2 shared publications- Xin Luo
The First Clinical Medical College of Jinan University, Guangzhou, China
2 shared publications Yan Yu
Department of Obstetrics and Gynecology, Shenzhen Baoan Women’s and Children’s Hospital, Jinan University, Shenzhen, China
2 shared publicationsYang Lu
Department of Obstetrics and Gynecology, Shenzhen Baoan Women’s and Children’s Hospital, Jinan University, Shenzhen, China
2 shared publications
Latest Publications
- Open Access
- 14 August 2021
- Published by Springer Nature in Cell Death Discovery
- Vol. 7 (1) , 1-9
IGF2BP2-modified circular RNA circARHGAP12 promotes cervical cancer progression by interacting m6A/FOXM1 manner
Emerging evidence indicates that circular RNA (circRNA) and N6-methyladenosine (m6A) play critical roles in cervical cancer. However, the synergistic effect of circRNA and m6A on cervical cancer progression is unclear. In the present study, our sequencing data revealed that a novel m6A-modified circRNA (circARHGAP12, hsa_circ_0000231) upregulated in the cervical cancer tissue and cells. Interestingly, the m6A modification of circARHGAP12 could amplify its enrichment. Functional experiments illustrated that circARHGAP12 promoted the tumor progression of cervical cancer in vivo and vitro. Furthermore, MeRIP-Seq illustrated that there was a remarkable m6A site in FOXM1 mRNA. CircARHGAP12 interacted with m6A reader IGF2BP2 to combine with FOXM1 mRNA, thereby accelerating the stability of FOXM1 mRNA. In conclusion, we found that circARHGAP12 exerted the oncogenic role in cervical cancer progression through m6A-dependent IGF2BP2/FOXM1 pathway. These findings may provide new concepts for cervical cancer biology and pathological physiology.
- 14 August 2021
- Published by Springer Nature in Cell Death Discovery
- Vol. 7 (1) , 1-9
Open AccessIGF2BP2-modified circular RNA circARHGAP12 promotes cervical cancer progression by interacting m6A/FOXM1 manner
Emerging evidence indicates that circular RNA (circRNA) and N6-methyladenosine (m6A) play critical roles in cervical cancer. However, the synergistic effect of circRNA and m6A on cervical cancer progression is unclear. In the present study, our sequencing data revealed that a novel m6A-modified circRNA (circARHGAP12, hsa_circ_0000231) upregulated in the cervical cancer tissue and cells. Interestingly, the m6A modification of circARHGAP12 could amplify its enrichment. Functional experiments illustrated that circARHGAP12 promoted the tumor progression of cervical cancer in vivo and vitro. Furthermore, MeRIP-Seq illustrated that there was a remarkable m6A site in FOXM1 mRNA. CircARHGAP12 interacted with m6A reader IGF2BP2 to combine with FOXM1 mRNA, thereby accelerating the stability of FOXM1 mRNA. In conclusion, we found that circARHGAP12 exerted the oncogenic role in cervical cancer progression through m6A-dependent IGF2BP2/FOXM1 pathway. These findings may provide new concepts for cervical cancer biology and pathological physiology.
- Open Access
- 21 July 2021
- Published by Elsevier in Molecular Therapy-Oncolytics
- Vol. 22, 574-581
m6A methyltransferase METTL3-mediated lncRNA FOXD2-AS1 promotes the tumorigenesis of cervical cancer
- 21 July 2021
- Published by Elsevier in Molecular Therapy-Oncolytics
- Vol. 22, 574-581
Open Accessm6A methyltransferase METTL3-mediated lncRNA FOXD2-AS1 promotes the tumorigenesis of cervical cancer
- Open Access
- 1 March 2020
- Published by Elsevier in Molecular Therapy Nucleic Acids
- Vol. 19, 413-420
Circular RNA circSLC26A4 Accelerates Cervical Cancer Progression via miR-1287-5p/HOXA7 Axis
- 1 March 2020
- Published by Elsevier in Molecular Therapy Nucleic Acids
- Vol. 19, 413-420
Open AccessCircular RNA circSLC26A4 Accelerates Cervical Cancer Progression via miR-1287-5p/HOXA7 Axis